US court reverses $482 million case against JNJ's Cordis
WASHINGTON, April 4
WASHINGTON, April 4 (Reuters) - Cordis Corp, a Johnson and Johnson subsidiary, did not infringe upon a stent patent owned by a radiologist, an appeals court said on Thursday, reversing a ruling by a lower court which had ordered Cordis to pay $482 million.
The U.S. Court of Appeals for the Federal Circuit reversed a ruling from a Texas jury, which had found Cordis guilty of infringement and ordered the payment, plus interest.
The appeals court ruled that Cordis had not infringed.
A lawyer for the radiologist, Bruce Saffran, was not immediately available.
The case in the U.S. District Court for the Eastern District of Texas was No. 07-CV-0451. The case at the U.S. Court of Appeals for the Federal Circuit is Bruce Saffran v. Johnson & Johnson and Cordis Corp., No. 2012-1043.
- French warplanes search Mali desert for crashed Air Algerie plane
- At least 15 die in Israeli shelling of Gaza school as toll exceeds 750 |
- Exclusive: Ukraine rebel commander acknowledges fighters had BUK missile
- Sierra Leone's chief Ebola doctor contracts the virus
- Minnesota man asked to leave Southwest flight after critical tweet